Marsh (MRSH) Earnings Date & Reports

Marsh & McLennan reported consolidated revenue of $7,597 million for the First Quarter 2026 (ended March 31), up 8% from $7,061 million in the prior-year quarter, driven by 4% underlying revenue growth (organic expansion adjusted for foreign exchange, acquisitions, and divestitures). This topped consensus estimates around $7.4 billion.

GAAP diluted EPS was $2.36, down from $2.79 YoY, reflecting a $425 million pre-tax charge related to the Greensill litigation, which also caused GAAP operating income to decline 12% to $1,754 million. Excluding this, adjusted operating income rose 8% to $2,413 million, with a stable adjusted margin of 31.8%.

Segment performance was solid: Risk & Insurance Services revenue grew 6% to $5,051 million (3% underlying), led by Marsh's 8% increase (4% underlying). Consulting revenue surged 11% to $2,558 million (5% underlying), with Mercer up 11%. Net income attributable to the company was $1.1 billion. Adjusted EPS of $3.29 exceeded forecasts by about 2%, marking another beat in a history of consistent outperformance.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your research workflow.

Market Reaction and Investor Sentiment

Following the April 16 release, MRSH shares rose in early trading, gaining around 4-5% initially before moderating, reflecting investor approval of the revenue and adjusted EPS beats despite the litigation charge. Sentiment turned positive on resilient underlying growth and stable margins, though some caution lingered over pricing headwinds in reinsurance and consulting demand signals. Options activity showed increased call buying, indicating optimism for sustained performance.

Forward Outlook and Key Factors to Monitor

Marsh & McLennan affirmed expectations for full-year 2026 underlying revenue growth similar to 2025's levels, navigating headwinds like softer insurance pricing and lower fiduciary interest income. CEO John Doyle highlighted market leadership and client trust as drivers of execution in a dynamic environment.

Investors should watch segment-specific trends: Marsh's risk advisory for renewal dynamics, Guy Carpenter's reinsurance book amid catastrophe losses, Mercer's health and wealth consulting amid economic uncertainty, and Oliver Wyman's strategy work. Cost discipline remains key, with compensation expenses up but offset by productivity gains.

Upcoming catalysts include Q2 results in July, potential M&A (mergers and acquisitions) activity given $750 million in share repurchases this quarter, and progress on AI-enhanced analytics for client solutions. Broader industry factors like interest rates and regulatory changes in insurance could influence margins.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations